Article Details

Lyvgen Announces Phase 2 Clinical Collaboration with Bristol Myers Squibb to Evaluate ...

Retrieved on: 2022-11-27 23:09:09

Tags for this article:

Click the tags to see associated articles and topics

Lyvgen Announces Phase 2 Clinical Collaboration with Bristol Myers Squibb to Evaluate .... View article details on hiswai:

Excerpt

LVGN7409, a recombinant monoclonal antibody that targets CD40 for activation optimally in tumor microenvironment, which is a member of the tumor ...

Article found on: www.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up